Physicians’ Views on Targeted Alpha-1 Antitrypsin Testing by Respiratory Therapists in PFT Labs and Their Awareness of Protections Offered by the Genetic Information Nondiscriminat... von Qureshi, Osman, Warda, Ali, Rahaghi, Nicholas F., Ferrer, Gustavo, Ramirez, Jose, Oliveira, Eduardo, Smolley, Laurence A., Rahaghi, Franck F.

Volltext

Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study von Rahaghi, Franck F, Kolaitis, Nicholas A, Adegunsoye, Ayodeji, de Andrade, Joao A, Flaherty, Kevin R, Lancaster, Lisa H, Lee, Joyce S, Levine, Deborah J, Preston, Ioana R, Safdar, Zeenat, Saggar, Rajan, Sahay, Sandeep, Scholand, Mary Beth, Shlobin, Oksana A, Zisman, David A, Nathan, Steven D

Volltext

Individual dose adjustment of riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension von Hill, Nicholas S, Rahaghi, Franck F, Sood, Namita, Frey, Reiner, Ghofrani, Hossein-Ardeschir

Volltext

Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat von Rahaghi, Franck F., Balasubramanian, Vijay P., Bourge, Robert C., Burger, Charles D., Chakinala, Murali M., Eggert, Michael S., Elwing, Jean M., Feldman, Jeremy, King, Christopher, Klinger, James R., Mathai, Stephen C., McConnell, John Wesley, Palevsky, Harold I., Restrepo‐Jaramillo, Ricardo, Safdar, Zeenat, Sager, Jeffrey S., Sood, Namita, Sulica, Roxana, White, R. James, Hill, Nicholas S.

Volltext

Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease von Rahaghi, Franck F., Kolaitis, Nicholas A., Adegunsoye, Ayodeji, de Andrade, Joao A., Flaherty, Kevin R., Lancaster, Lisa H., Lee, Joyce S., Levine, Deborah J., Preston, Ioana R., Safdar, Zeenat, Saggar, Rajan, Sahay, Sandeep, Scholand, Mary Beth, Shlobin, Oksana A., Zisman, David A., Nathan, Steven D.

Volltext

Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial von Frantz, Robert P, McLaughlin, Vallerie V, Sahay, Sandeep, Escribano Subías, Pilar, Zolty, Ronald L, Benza, Raymond L, Channick, Richard N, Chin, Kelly M, Hemnes, Anna R, Howard, Luke S, Sitbon, Olivier, Vachiéry, Jean-Luc, Zamanian, Roham T, Cravets, Matt, Roscigno, Robert F, Mottola, David, Osterhout, Robin, Bruey, Jean-Marie, Elman, Erin, Tompkins, Cindy-ann, Parsley, Ed, Aranda, Richard, Zisman, Lawrence S, Ghofrani, Hossein-Ardeschir, Adir, Yochai, Baillie, Timothy, Baratz, David, Burger, Charles, Chakinala, Murali M., Cifrián Martínez, Jose Manual, Delcroix, Marion, Dwyer, Nathan, Elwing, Jean M., Fisher, Micah, Franco, Veronica, Grünig, Ekkehard, Highland, Kristin, Hill, Nicholas, Hirani, Naushad, Hoeper, Marius, Jansa, Pavel, Keogh, Anne, Kingrey, John, Lopez-Meseguer, Manuel, McConnell, John W., Mehta, Sanjay, Melendres-Groves, Lana, Opitz, Christian, Pepke-Zaba, Joanna, Pillutla, Priya, Rahaghi, Franck, Raina, Amresh, Raviv, Yael, Robinson, Jeffrey, Ryan, John, Sager, Jeffrey, Shapiro, Shelley, Simon, Marc, Smith, Kerri, Sobol, Irina R., Sood, Namita, Spikes, Leslie A., Stadler, Stefan, Stevens, Wendy, Sulica, Roxana, White, R. James

Volltext